"Antigens, Ly" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of lymphocyte surface antigens located on mouse LYMPHOCYTES. Specific Ly antigens are useful markers for distinguishing subpopulations of lymphocytes.
Descriptor ID |
D000950
|
MeSH Number(s) |
D23.050.301.264.920 D23.101.100.920
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Ly".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Ly".
This graph shows the total number of publications written about "Antigens, Ly" by people in this website by year, and whether "Antigens, Ly" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Ly" by people in Profiles.
-
MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014 Apr; 34(4):759-67.
-
Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients. Atherosclerosis. 2012 Aug; 223(2):291-8.
-
Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent. Circulation. 2011 Jul 26; 124(4):454-64.
-
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. J Immunother. 2007 Jan; 30(1):40-53.
-
CD38 expression by hematopoietic stem cells of newborn and juvenile mice. Leukemia. 2003 Jan; 17(1):171-4.
-
CD34 expression by murine hematopoietic stem cells. Developmental changes and kinetic alterations. Ann N Y Acad Sci. 2001 Jun; 938:139-45.
-
Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999 Oct 15; 94(8):2548-54.
-
In vitro expansion of hematopoietic stem cells. Stem Cells. 1997; 15 Suppl 1:7-11; discussion 12.
-
Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alpha. Blood. 1995 Dec 15; 86(12):4527-31.
-
Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties. Cell Immunol. 1990 May; 127(2):442-57.